Associated Banc-Corp enters the back half of April with a notable divergence: a strong recovery in price, cautious-but-improving analyst sentiment, and short sellers quietly trimming positions after a brief build-up earlier in the month.
The stock closed at $28.15 on April 28, up nearly 1% on the week and 13% over the past month — a sharp recovery that has compressed the distance to the Street's mean price target of $30.80. That rebound follows Q1 earnings reported April 23, which produced a muted one-day reaction of –1.8%, a soft print that masked some underlying positives the Street was quick to reassess.
Analysts moved quickly after the results. Multiple firms raised their price targets within 48 hours of the print: Keefe Bruyette & Woods lifted to $31, while Piper Sandler, Baird, and Truist all moved to $30. No one upgraded their rating — the dominant call remains Hold or Neutral — but the direction of target revisions tells a cleaner story than the ratings themselves. Earlier in April, Barclays had already upgraded ASB to Overweight with a $33 target, the most bullish voice on the street right now. The bull case rests on net interest income growth, a 3.06% margin, and the pending acquisition of American National. Bears point to slipping fee income and rising core expenses, with concerns that a slowing economy could pressure asset quality. Analyst return potential is around 9.4%, which is respectable for a Hold-heavy consensus.
Short positioning has been broadly stable, and the lending market is extremely relaxed. SI has eased about 3.5% over the past week to 3.7% of free float — modest at this level and not a primary driver of the price story. Cost to borrow is near its lowest point of the past month at 0.37%, down sharply on the week, and availability is wide open. That combination tells a clear story: there is no meaningful short-side pressure in ASB right now, and no squeeze dynamic is building.
Options traders are leaning bullish, not defensive. The put/call ratio is running well below its 20-day average — 0.22 versus a mean of 0.24 — and the z-score of –1.47 places current positioning toward the call-heavy end of recent history. That's consistent with the price recovery and suggests the options market is not pricing in an imminent reversal.
Institutional ownership is broadly passive and stable. BlackRock and Vanguard hold the top two spots at 11.3% and 9.8% respectively, with incremental adds in the most recent quarter. First Trust's addition of over 2 million shares in Q1 stands out as a meaningful active allocation, even if unaccompanied by public commentary. On the insider side, a small sale by Chairman John Williams on April 28 — 4,000 shares at $28.18 — is routine in size and not a signal in isolation. The more notable cluster of March 9 insider selling by the CEO and several EVPs at $25.08 now looks like standard post-vest activity, given how far the stock has since moved. The 90-day net insider position is actually positive at roughly 313,000 shares.
EPS momentum is one of the brighter spots in the ORTEX factor profile. The stock ranks in the 82nd percentile on 30-day EPS momentum and 71st on the 90-day measure, signalling that forward estimates are being revised higher at a pace that outpaces most of the peer group. The dividend score sits in the 85th percentile. Price-to-book is running just under 1x, and the PE is around 9.2x — undemanding multiples for a bank navigating a tricky macro environment. The ORTEX short score of 34.7 is benign and has barely moved all month, reflecting the absence of any meaningful bearish build.
Closely correlated peers have had a quieter week. ONB edged up 0.9% and ZION added 1.9%, while FULT slipped 0.6% — all broadly in line with ASB's own modest weekly gain. The regional bank group appears to be consolidating rather than breaking in either direction.
The next scheduled catalyst is Q2 earnings on July 23. Between now and then, the key variable to watch is whether the American National acquisition clears regulatory hurdles on schedule — the Street's more constructive targets are partly built around that deal closing.
See the live data behind this article on ORTEX.
Open ASB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
